ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION

Lobbying client · District of Columbia · filed 2025 to 2026

Biopharmaceutical industry

$1,590,000 Reported spend

6 Filings counted

1 Firms hired

11 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (179012), not by name.

Firms hired 1

THE WASHINGTON TAX & PUBLIC POLICY GROUP $1,590,000 6 filings

Bills named in these filings 11

HR 1062
Growing and Preserving Innovation in America Act of 2025

4 filings
HR 1347
AIMM Act

4 filings
HR 1990
American Innovation and R&D Competitiveness Act of 2025

4 filings
HR 574
ALIGN Act

4 filings
S 187
ALIGN Act

4 filings
S 559
AIMM Act

4 filings
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

3 filings
S 1605
International Competition for American Jobs Act

3 filings
S 1688
Growing America’s Small Businesses and Manufacturing Act

3 filings
S 2021
Close the Round-Tripping Loophole Act

3 filings
S 1639
American Innovation and Jobs Act

2 filings

Reported by year 2 years

2026 $550,000 2 filings
2025 $1,040,000 4 filings

Issues lobbied 1

Taxation/Internal Revenue Code 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 6
SENATE 6
Treasury, Dept of 1

Recent filings 6 total

Q2

THE WASHINGTON TAX & PUBLIC POLICY GROUP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 9, 2026

View → Q1

THE WASHINGTON TAX & PUBLIC POLICY GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $500,000 income · posted Apr 1, 2026

View → Q4

THE WASHINGTON TAX & PUBLIC POLICY GROUP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $70,000 income · posted Jan 13, 2026

View → Q3

THE WASHINGTON TAX & PUBLIC POLICY GROUP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $450,000 income · posted Oct 14, 2025

View → Q2

THE WASHINGTON TAX & PUBLIC POLICY GROUP

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $70,000 income · posted Jul 8, 2025

View → Q1

THE WASHINGTON TAX & PUBLIC POLICY GROUP

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $450,000 income · posted Apr 8, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.